GME vs SRPT · P/E 16, rev $3.63B vs rev $1.13B
GameStop Corp. (GME) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
GameStop Corp. (GME) is a specialty retail company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported GME revenue for 2026-01-31 was $3.63B. Net income was $418.4M. Revenue was down 5.1% from 2025-02-01 to 2026-01-31. GME currently screens at market cap $9.78B and trailing P/E 16.3.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
GME currently screens at market cap $9.78B and trailing P/E 16.3. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the GME and SRPT stock pages for the full models.
Not investment advice.